Strain information  NBRP Rat No: 0455  Strain name: F344-Scn1am1Kyo  Commmon Name: F344/NSlc-Scn1aKyo811 Rat Genome Database Principal Investigator:  Tadao Serikawa  Graduate School of Medicine, Kyoto University       Yoshidakonoe-cho, Sakyo-ku    606-8501 Kyoto     JAPAN Tel: 075-753-4360    Fax: 075-753-4409 Email: serikawa@anim.med.kyoto-u.ac.jp Preservation Status:   Embryo        Sperm       Living Animals Coat Color  albino (c) Inbred Generations  N11F5 (April 2012) Usage Restrictions   The recipient of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. For a commercial use of this resource, a new contract must be concluded between the depositor and the recipient. Genetic Status   Inbred  Segregating   Congenic   Consomic   Recombinant   Coisogenic   Spont. Mutant  Transgene  Ind. Mutant  Category Other  Comercial Availability Research Category   Diabetes Obesity  Neurobiology  Ophthalmology   Dentistry  Cardio Hypertension  Cancer  Metabolism  Otorhinology  Immunology  Infectious  Osteosis   Internal Organ  Dermatology   Reproduction   Development  Behavior  Hematology  Urology   Pharmacology  Research Area Others   Control Strain  Marker Strain Gene Affected Scn1a: sodium channel, voltage-gated, type I, alpha Origin This strain was established by ENU mutagenesis (gene-driven). This strain possesses a point mutation in the Scn1a gene (N1417H) (Mashimo, 2010). Hyperthermia-induced seizure-susceptible (Hiss) rat. (May 26, 2010) Strain characteristics A point mutation in Scn1a gene. This strain possesses a missense mutation (N1417H) in the third pore region of the sodium channel, Scn1a. Despite their normal appearance under ordinary circumstances, Scn1a mutant rats exhibited remarkably high susceptibility to hyperthermia-induced seizures. Scn1a is a causative gene for human GEFS+. Immunohistochemical analysis revealed that hyperthermic seizures induced a widespread elevation of Fos-immunoreactivity in the cerebral cortices and limbic regions (Ohno, 2010). This rat showed a significantly lower threshold in epileptiform discharges in response to local stimulation of the hippocampus. Diazepam and sodium valproate are effective to hyperthermic seizure of this rat (Ohno, 2010). (Oct 11, 2010) Breeding Conditions Good breeding performance. Genotyping Genotyping protocol for　Scn1am1Kyo References Serikawa T, Mashimo T, Kuramoto T, Voigt B, Ohno Y, Sasa M. Advances on Genetic Rat Models of Epilepsy. Exp Anim. 2015 Feb 5;64(1):1-7. Ohmori I, Kawakami N, Liu S, Wang H, Miyazaki I, Asanuma M, Michiue H, Matsui H, Mashimo T, Ouchida M. Methylphenidate improves learning impairments and hyperthermia-induced seizures caused by an Scn1a mutation. Epilepsia. 2014 Oct;55(10):1558-67. Ohmori I, Hayashi K, Wang H, Ouchida M, Fujita N, Inoue T, Michiue H, Nishiki T, Matsui H. Inhalation of 10% carbon dioxide rapidly terminates Scn1a mutation-related hyperthermia-induced seizures. Epilepsy Res. 2013 Jul;105(1-2):220-4. Ohno Y, Ishihara S, Mashimo T, Sofue N, Shimizu S, Imaoku T, Tsurumi T, Sasa M, Serikawa T. Scn1a missense mutation causes limbic hyperexcitability and vulnerability to experimental febrile seizures. Neurobiol Dis. 41(2):261-269, 2011. Hayashi K, Ueshima S, Ouchida M, Mashimo T, Nishiki T, Sendo T, Serikawa T, Matsui H, Ohmori I. Therapy for hyperthermia-induced seizures in Scn1a mutant rats. Epilepsia 52(5):1010-1017, 2011 Ohno Y, Sofue N, Ishihara S, Mashimo T, Sasa M, Serikawa T. Scn1a missense mutation impairs GABA(A) receptor-mediated synaptic transmission in the rat hippocampus. Biochem Biophys Res Commun. 2010 Sep 10;400(1):117-22. Mashimo T, Ohmori I, Ouchida M, Ohno Y, Tsurumi T, Miki T, Wakamori M, Ishihara S, Yoshida T, Takizawa A, Kato M, Hirabayashi M, Sasa M, Mori Y, Serikawa T. A missense mutation of the gene encoding voltage-dependent sodium channel (Nav1.1) confers susceptibility to febrile seizures in rats. J Neurosci. 2010 Apr 21;30(16):5744-53. Additional strain information